Due to the COVID-19 Coronavirus outbreak, the Cell Symposia: Infection Biology in the Age of the Microbiome will now take place December 9–11, 2020.
We understand you may be concerned about not being able to attend due to the Coronavirus COVID-19 situation. Rest assured that we will refund your registration fee, with no penalty, should you wish to cancel during the uncertainty of the outbreak.
The Elsevier conference team take the safety and well-being of their entire delegation and community very seriously. We will therefore be implementing a number of enhanced hygiene and cleaning measures, in collaboration with our conference venues, when our events take place. We will also of course, be following appropriate social distancing measures, to keep everyone safe throughout the conference.
This is coupled with our promise to refund your registration fee, with no penalty, should you wish to cancel during the uncertainty of the outbreak.
REVISED SYMPOSIA DATES: DECEMBER 9–11, 2020
EARLY REGISTRATION DEADLINE OCTOBER 16, 2020
REGISTER EARLY & SAVE €100
Cell Symposia: Infection Biology in the Age of the Microbiome
December 9–11, 2020 | Paris, France
Classical studies of microbiology neglected the roles of resident communities, within which most pathogens function, creating simpler models for studying infection. Traditionally, this area of research has been separate from studies of so-called good bugs. Yet recently, a microbial community view of pathogenesis has taken shape: one in which molecules, machinery, and mechanisms that were discovered studying bacterial infection are now being applied to understand the interplay between pathogens, resident microbes, and the host environment. The integration of next-generation sequencing, metabolomics, and genome-engineering techniques has expanded the horizons of infection biology, enabling the interrogation of increasingly complex systems.
The meeting will explore bacterial pathogens and pathogenesis from multiple perspectives, from cellular mechanisms to interbacterial interactions and community behavior, as well as pathogenesis in the complex milieu of the microbiota. The meeting will also highlight the pathogenic potential of the microbiome and explore microbiota-based and engineered antibacterial/therapeutic approaches.
Our topics will include:
- Bacterial communication and signaling
- Interbacterial and interkingdom interactions
- Pathogen interactions with hosts and microbiomes
- Commensal homeostasis and dysbiosis
- Microbiome-based opportunities for therapy
This innovative program will unite pathogenesis stalwarts with microbiome pioneers to share their collective knowledge—spanning molecules, microbes, and communities — to envision the future of infection biology research and therapeutic intervention.
- Emily Balskus, USA
- Andreas Baumler, USA
- Yasmine Belkaid, USA
- Carmen Buchrieser, France
- Laurent Debarbieux, France
- Kevin Foster, UK
- Andrew Gewirtz, USA
- Karine Gibbs, USA
- Andrew Goodman, USA
- Karen Guillemin, USA
- Purna Kashyap, USA
- Ruth Ley, Germany
- Ilan Rosenshine, Israel
- June Round, USA
- Vanessa Sperandio, USA
- Nassos Typas, Germany
Seattle, WA, USA
San Francisco, CA, USA
San Francisco, CA, USA
October 20 — 22, 2019
Chicago, IL, USA
September 22 — 24, 2019
Long Beach, CA, USA
August 25 – 27, 2019
San Diego, CA, USA
May 12 - 14, 2019